Earnings Alerts

China Molybdenum Co Ltd H (3993) Earnings Skyrocket with Prelim FY Net Income Rising by 36%

  • CMOC Group has reported a preliminary Full Year Net Income increase of 36%.
  • The preliminary net income is reported to be 8.25 billion yuan.
  • The company’s preliminary revenue stands at 186.27 billion yuan.
  • Currently, the company has 13 buys, with no holds or sells.

A look at China Molybdenum Co Ltd H Smart Scores

FactorScoreMagnitude
Value3
Dividend4
Growth4
Resilience3
Momentum5
OVERALL SMART SCORE3.8

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, China Molybdenum Co Ltd H has a promising long-term outlook. With a score of 3 for value, the company is considered fairly valued in the market. This indicates that investors may see potential for growth and profitability in the future. Additionally, with a score of 4 for both dividend and growth, China Molybdenum Co Ltd H is showing strong potential for generating returns for its shareholders. The company also scores a 3 for resilience, suggesting that it has the ability to withstand market fluctuations and challenges. Finally, with a perfect score of 5 for momentum, China Molybdenum Co Ltd H is exhibiting strong upward momentum and may be a good investment for those looking for a company with strong growth potential.

China Molybdenum Co Ltd H operates as a mineral mining and exploration company, with a focus on molybdenum, tungsten, niobium, cobalt, copper, and other minerals. The company conducts business globally, which provides opportunities for expansion and diversification. With a strong overall outlook based on the Smartkarma Smart Scores, China Molybdenum Co Ltd H may be a company worth considering for long-term investment. Investors should keep an eye on the company’s performance and potential growth in the coming years.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars